/
NSRX
$3.45+$0.13 (+3.92%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$38.9M
12M shares
52-week range
$1.98 – $9.99
18% from low
Exchange
XASE
CS
Borrow rate
20.64%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-4.80
Nasus Pharma Ltd.
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
www.nasuspharma.com- Employees
- 7
- IPO / List date
- Aug 13, 2025
Held by traders on TradeandTell
No one on the platform currently holds NSRX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NSRX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NSRX yet.
